Tenax Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $97.6M | $94.9M | $9.8M | $2.1M | $5.6M | $6.3M | $4.9M | $12.4M |
| Accounts Receivable | — | — | — | — | — | — | — | $0 |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $104.2M | $96.7M | $11.7M | $3.2M | $5.7M | $6.8M | $6.2M | $13.3M |
| Property, Plant & Equipment | — | — | $0 | $7.2K | $7.1K | $6.0K | $6.6K | $8.5K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $104.2M | $96.7M | $11.7M | $3.4M | $6.0M | $6.9M | $6.4M | $13.3M |
| Liabilities | ||||||||
| Accounts Payable | $6.0M | $3.2M | $2.1M | $448.4K | $859.6K | $757.9K | $1.7M | $749.8K |
| Total Current Liabilities | $7.2M | $4.7M | $3.6M | $1.8M | $1.6M | $2.1M | $2.5M | $1.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.2M | $4.7M | $3.6M | $1.9M | $1.7M | $2.2M | $2.6M | $1.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-367.5M | $-314.9M | $-297.3M | $-289.5M | $-278.5M | $-246.0M | $-236.2M | $-227.8M |
| Total Stockholders' Equity | $97.1M | $92.0M | $8.1M | $1.5M | $4.2M | $4.6M | $3.8M | $11.8M |